RE:RE:One thing is for sure...jojomarch wrote: Longholder99 wrote: When the Ph2 results start rolling in, and the FDA hurdle is cleared. No matter who is involved....Frost...Merck....Roche....Sanofi.....pick one or add your own. Its gonna get interesting. Its only a matter of time before the gloves come off and it's all going to happen fast IMO.
LaserStock mentioned Medtronic , the CEO of MDT was on Mad Money tonight . I think our fellow poster is on to something ....great company , great fit . I watched the interview , cutting edge technology .
Cheers
Appreciate the shout out.
I already eliminated Merck (FDA Bladder and Lung China), Novartis (2.1 b on Endocyte) and Roche
Tecentriq Lung..... based on their investment lead asset portfolio from 2020 to 2022....
Sanofi Pipeline Assuming TLT wants to keep 100% ownership of Bladder. Sanofi has NSCLC.. which is the big kahuna burger..
So i consider them eliminated.
You kinda need a device to access the peripheral lung..... that's what was going on with our SPIE 2019 paper....
I already asked the board... to contribute to eliminating the major pharmas.. but no one wanted to play jeporady.
the list gets mighty thin... when u put the varibles together.
Would love to be the first photodynamic theraphy in China in 2020 when that Innovation Centre opens.
Would hate it if Roger allowed those scientists to finish testing the Iridium Photodynamics and start in China doing indications.
Got to be nimble... be quick......jump that candlestick JACK.